rosuvastatin calcium 20 MG Oral Tablet [Crestor]
rosuvastatin calcium
RxCUI: 859753
What the CMS Formulary Data Shows for rosuvastatin calcium 20 MG Oral Tablet [Crestor]
Per the CMS 2026 Part D formulary file, rosuvastatin calcium 20 MG Oral Tablet [Crestor] (RxNorm concept RXCUI 859753, generic name rosuvastatin calcium) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to rosuvastatin calcium 20 MG Oral Tablet [Crestor] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 100% require step therapy. 100% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 6,945,233 Part D beneficiaries filled rosuvastatin calcium 20 MG Oral Tablet [Crestor] in 2023, with total plan-and-beneficiary spending of $604,421,766 and an average per-beneficiary annual cost of $87.03. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry rosuvastatin calcium 20 MG Oral Tablet [Crestor] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 2
- Coverage rate
- 0%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 100% of formularies
- Quantity limits
- 100% of formularies
2023 Medicare Spending
- Beneficiaries
- 6,945,233
- Total spending
- $604,421,766
- Avg per beneficiary
- $87.03
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering rosuvastatin calcium 20 MG Oral Tablet [Crestor]
2 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is rosuvastatin calcium 20 MG Oral Tablet [Crestor] covered by Medicare Part D?
Yes, rosuvastatin calcium 20 MG Oral Tablet [Crestor] is covered by 2 Medicare Part D plans (0% of all Part D formularies).
What tier is rosuvastatin calcium 20 MG Oral Tablet [Crestor] on Medicare Part D plans?
rosuvastatin calcium 20 MG Oral Tablet [Crestor] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does rosuvastatin calcium 20 MG Oral Tablet [Crestor] require prior authorization?
0% of Part D formularies require prior authorization for rosuvastatin calcium 20 MG Oral Tablet [Crestor]. Step therapy: 100%. Quantity limits: 100%.
How much does Medicare spend on rosuvastatin calcium 20 MG Oral Tablet [Crestor]?
In 2023, total Medicare Part D spending on rosuvastatin calcium 20 MG Oral Tablet [Crestor] was $604,421,766, covering 6,945,233 beneficiaries. The average spend per beneficiary was $87.03.
Read our methodology - how this data is sourced, computed, and verified.